Fortrea
The Executive Director, Clinical Platforms & Product Development leads the strategic definition, engineering, and operational execution of Fortrea's clinical technology ecosystem. This senior role drives end-to-end product lifecycles, manages complex delivery operations, and partners with stakeholders to ensure scalable, compliant solutions for the clinical trial industry. The position requires deep expertise in digital health, enterprise application development, and navigating the regulated pharmaceutical environment.
Headquarters
Lake Park, North Carolina, United States
Company Size
10001+ employees
Fortrea, a leading CRO, advancing clinical trials through patient-focused clinical solutions that accelerate clinical development, drive trial success, and bring innovative therapies to those who need them most.
Fortrea (NASDAQ:FTRE) CFO Sells $45,903.27 in Stock
16 hours ago
High-Risk Small-Cap Stocks: AGCO, Fortrea, Insperity Financial Warnings - News and Statistics
33 minutes ago
Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
1 day ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Fortrea.
Fortrea didn’t post a salary, so this is our estimate from similar listings.
15% above the average for this role
Fortrea Stock Pre-Market (+4.2%): Upgraded to Buy at TD Cowen on Improved Outlook
2 days ago
Executive Director, Clinical Platforms and Product Development
lifelancer
Executive Director, Clinical Platforms & Product Development
lifelancer
Executive Director, Clinical Platforms and Product Development
lifelancer
Executive Director, Clinical Platforms & Product Development
lifelancer
Senior Product Owner, WPP Open
WPP
Product Owner - Clinical Trial Supplier Enablement
Amgen